List of insiders holdings for Replimune Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
2025-03-07 17:07:29 | 11,045,336 0 |
11,045,336 | Form 13D |
| 2 | Redmile Group LLC Green Jeremy 10% Owner |
2025-05-15 21:01:33 | 4,898,527 0 |
4,898,527 | Form 13G |
| 3 | Forbion Capital Fund III Cooperatief U.A. 10% Owner |
2025-02-14 09:00:03 | 4,219,340 0 |
4,219,340 | Form 13G |
| 4 | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Lim Richard J. Paster Anne-Mari 10% Owner |
2024-11-14 08:35:56 | 2,709,991 0 |
2,709,991 | Form 13G |
| 5 | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello 10% Owner |
2024-11-14 08:35:56 | 2,709,991 0 |
2,709,991 | Form 13G |
| 6 | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Paster Anne-Mari Director 10% Owner |
2024-11-14 08:35:56 | 2,709,991 0 |
2,709,991 | Form 13G |
| 7 | Coffin Robert Director |
2024-05-20 20:02:44 | 1,821,872 0 |
1,821,872 | Form 4 |
| 8 | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. 10% Owner |
2022-12-06 17:00:05 | 1,498,635 0 |
1,498,635 | Form 13D |
| 9 | Atlas Venture Fund X L.P. 10% Owner |
2022-12-06 17:00:05 | 1,498,635 0 |
1,498,635 | Form 13D |
| 10 | Astley-Sparke Philip Director |
2025-05-22 21:47:07 | 1,405,071 0 |
1,405,071 | Form 4 |
| 11 | Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC See Remarks |
2019-11-20 17:49:10 | 0 1,100,000 |
1,100,000 | Form 3 |
| 12 | Love Colin Chief Operating Officer |
2024-05-20 20:05:37 | 777,345 0 |
777,345 | Form 4 |
| 13 | Esposito Pamela Chief Business Officer |
2023-09-13 21:02:56 | 435,802 0 |
435,802 | Form 4 |
| 14 | Patel Sushil Chief Executive Officer |
2025-05-22 21:44:48 | 343,576 0 |
343,576 | Form 4 |
| 15 | Kaufman Howard Chief Medical Officer |
2019-12-19 16:02:37 | 149,202 0 |
149,202 | Form 4 |
| 16 | Xynos Konstantinos Chief Medical Officer |
2025-05-22 21:46:09 | 146,933 0 |
146,933 | Form 4 |
| 17 | Hill Emily Luisa Chief Financial Officer |
2025-05-22 21:44:01 | 143,522 0 |
143,522 | Form 4 |
| 18 | Lewis Tanya Chief Dev. Op. Officer |
2023-06-15 21:01:04 | 135,293 0 |
135,293 | Form 4 |
| 19 | Franchi Jean M. Chief Financial Officer |
2023-05-18 20:32:47 | 128,748 0 |
128,748 | Form 4 |
| 20 | Sarchi Christopher Chief Commercial Officer |
2025-05-22 21:42:32 | 128,296 0 |
128,296 | Form 4 |
| 21 | Schwendenman Andrew Chief Accounting Officer |
2025-05-22 21:45:30 | 68,284 0 |
68,284 | Form 4 |
| 22 | GORGOL STEPHEN A Chief Accounting Officer |
2020-04-02 16:35:33 | 66,050 0 |
66,050 | Form 4 |
| 23 | Pirzkall Andrea Chief Medical Officer |
2021-04-05 20:19:45 | 52,250 0 |
52,250 | Form 4 |
| 24 | Oliger Christy J. Director |
2025-04-03 20:00:50 | 32,000 0 |
32,000 | Form 4 |
| 25 | Peeples-Dyer Veleka Director |
2025-04-03 20:06:46 | 32,000 0 |
32,000 | Form 4 |
| 26 | Pucci Paolo Director |
2025-04-03 20:05:36 | 32,000 0 |
32,000 | Form 4 |
| 27 | Balachandran Madhavan Director |
2025-04-03 20:05:09 | 32,000 0 |
32,000 | Form 4 |
| 28 | Dhingra Kapil Director |
2025-04-03 20:03:31 | 32,000 0 |
32,000 | Form 4 |
| 29 | SLATTERY JOSEPH P Director |
2025-04-03 20:02:59 | 32,000 0 |
32,000 | Form 4 |
| 30 | Weinand Dieter Director |
2025-04-03 20:01:48 | 32,000 0 |
32,000 | Form 4 |
| 31 | Levitsky Hyam Director |
2024-04-03 20:00:27 | 32,000 0 |
32,000 | Form 4 |
| 32 | Slootweg Hugo Alexander Director |
2023-04-04 20:04:24 | 25,200 0 |
25,200 | Form 4 |
| 33 | Rhodes Jason P Director |
2022-04-05 16:13:35 | 16,500 0 |
16,500 | Form 4 |
| 34 | GOLLER MICHAEL Director |
2025-03-07 17:00:33 | 0 0 |
0 | Form 3 |
| 35 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
2021-02-16 15:15:05 | 0 0 |
0 | Form 13G |